EyePoint, Inc. Loss Contingency, Estimate of Possible Loss
EyePoint, Inc. (EYPT) had Loss Contingency, Estimate of Possible Loss of $4.70 million as of 2026-03-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2026-08-05
- 2026-03-31: Loss Contingency, Estimate of Possible Loss $4.70M.
- 2025-12-31: Loss Contingency, Estimate of Possible Loss $4.70M.
- 2025-09-30: Loss Contingency, Estimate of Possible Loss $4.70M.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2026-03-31 | $4.70M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $4.70M 10-K · filed 2026-03-05 |
| 2025-09-30 | $4.70M 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |